covid vaccine and semaglutide Pfizer's COVID-19 trial data shows long-term efficacy in adolescents Study finds weight loss drug

On paper, this sounds great

Why Constipation is So Common Constipation is especially common with semaglutide because of its impact on the digestive systems speed

Because of this dual action, tirzepatide may produce greater average weight loss for some patients

Liraglutide (Saxenda): The Original Weight Loss GLP-1 Liraglutide was the first GLP-1 receptor agonist to receive FDA approval specifically for chronic weight management, doing so in 2014 under the brand name Saxenda

Originally developed as a medication for managing Type 2 diabetes, semaglutide has a unique ability to mimic a hormone called GLP-1 (glucagon-like peptide-1), which regulates appetite and blood sugar levels